Navigation Links
Treatment Resistant Tumors Can Be Targeted Better Using Botox

Botox, commonly used for cosmetic treatment may play an important role in enhancing the outcome of chemotherapy and radiotherapy, employed in cancer treatment. // Botox is a derivative of Botulinum toxin, a naturally occurring chemical known to cause intestinal poisoning.

The toxin has numerous clinical applications such as relieving facial spasms, strabismus and treating muscle hyperactivity. The toxin acts by blocking release of acetylcholine and norepinephrine (neurotransmitters).

It is hypothesized that this neurotransmitter release inhibition could inhibit neuromuscular contraction of blood vessels that supply the tumor. This could eventually pave way for enhanced tumor perfusion, allowing effective delivery of cytotoxic drugs and oxygen (improves tumor response to radiotherapy) supplied to the tumor.

To verify the above hypothesis, Dr. Bernard Gallez and his research team injected Botulinum neurotoxin (Type A) into mouse tumors. As expected, the vascular architecture of the tumor opened, destroying the previously resistant cancer cells. The study is the first of its kind to test the use of Botox as an adjuvant in the effective treatment of resistant tumors.

In addition, pre-treatment with Botox delayed further growth of the tumor and promoted apoptosis, that could enhance the clinical outcome of cancer treatment. Based on further research in the same direction, it might even be possible to overcome drug resistance or reduce standard radiotherapy and chemotherapy dosages, thereby eliminating the associated side effects.

Until now, much of cancer treatment has been focused towards starving the tumor of its blood supply. This new approach, targeted at enhanced blood supply for effective delivery of chemotherapeutic agents and radiation represents a new dimension of cancer research.

'Tumor vasculature is targeted by several advanced anti-cancer approaches that may appear contradic tory. Anti-angiogenesis and anti-vascular targeting are methods aimed at destroying the vessels that feed tumors, thereby depriving them of oxygen and nutrients. In contrast, pro-vascular approaches increase tumor perfusion and oxygenation temporarily,' concluded Dr. Gallez.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced two key appointments and the opening of ... strategic growth plans in the Asia Pacific region. , Howard Kim has joined ...
(Date:5/26/2016)... , ... May 26, 2016 , ... In an effort to provide hair restoration information ... both Snapchat users and those who do not use the app. Dr. Mohebi, the founder ... page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... comprehensive treatment for eating disorders, is opening a brand new child and adolescent ... ages 8-17 and their families with even more specialized eating disorder treatment and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 According to the ... is driving ambulatory blood pressure monitoring system market growth. ... their ability to respond to different pressure rates, leading ... lead to various cardiovascular disorders such as heart failure, ... diseases are growing in prevalence each year. WHO estimates ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... 2016 Kitov Pharmaceuticals ... on late-stage drug development, today announced the completion ... pivotal batches required for registration of KIT-302 with ... follows Kitov,s announcement in December 2015, ... its primary efficacy endpoint. "We are ...
Breaking Medicine Technology: